An audit of docetaxel for 2nd line treatment of patients with advanced non small cell lung cancer (NSCLC): toxicities and outcomes in NHS Tayside 2005-2010

S. Capaldi, H. Lord, E. M. Rankin, E. Brown

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)S7
    Number of pages1
    JournalLung Cancer
    Volume75
    DOIs
    Publication statusPublished - 2012

    Cite this